GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ABION Inc (XKRX:203400) » Definitions » Research & Development

ABION (XKRX:203400) Research & Development : ₩21,414 Mil (TTM As of Mar. 2024)


View and export this data going back to 2014. Start your Free Trial

What is ABION Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. ABION's Research & Development for the three months ended in Mar. 2024 was ₩4,955 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 was ₩21,414 Mil.

ABION Research & Development Historical Data

The historical data trend for ABION's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ABION Research & Development Chart

ABION Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only 4,792.90 7,797.69 5,701.84 18,384.67 23,697.19

ABION Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7,238.25 2,206.99 8,212.93 6,039.02 4,955.29

ABION Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩21,414 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ABION  (XKRX:203400) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

ABION Research & Development Related Terms

Thank you for viewing the detailed overview of ABION's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

ABION (XKRX:203400) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ABION Inc (XKRX:203400) » Definitions » Research & Development
Comparable Companies
XKRX:166480 XKRX:234690 XKRX:348080 XKRX:353810 XKRX:365270 XKRX:389030 XKRX:067370 XKRX:251120 XKRX:065660 XKRX:261780 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
9th FI, HanWha Biz Metro Building, 242 Digital-ro, Guro-gu, Seoul, KOR, 08394
Website
http://www.abionbio.com
ABION Inc is a biopharmaceutical company. It is primarily involved in the research and development new bio pharmaceutical drugs and companion diagnostics systems for the treatment of incurable diseases.

ABION (XKRX:203400) Headlines

No Headlines